Table 1

Risk of gastric and non-cardia gastric adenocarcinoma in individuals receiving Helicobacter pylori eradication treatment in Sweden from 2005 to 2012 compared with the Swedish standard population, expressed as standardised incidence ratio (SIR) with 95% CI

Gastric adenocarcinomaNon-cardia gastric adenocarcinomaCardia adenocarcinoma
Number of casesSIR (95% CI)Number of casesSIR (95% CI)Number of casesSIR (95% CI)
Total752.08 (1.63 to 2.60)692.64 (2.06 to 3.35)60.60 (0.22 to 1.30)
Follow-up time, years
 1–3483.39 (2.50 to 4.50)434.20 (3.04 to 5.66)51.28 (0.41 to 2.98)
 3–5212.32 (1.44 to 3.55)203.08 (1.88 to 4.76)10.39 (0.00 to 2.19)
 5–7.561.48 (0.54 to 3.21)62.06 (0.75 to 4.48)0NA
No of eradications
 1611.88 (1.44 to 2.41)562.38 (1.80 to 3.10)50.56 (0.18 to 1.30)
 282.84 (1.22 to 5.59)73.45 (1.38 to 7.11)11.26 (0.02 to 7.02)
 >267.44 (2.72 to 16.19)610.47 (3.82 to 22.78)0NA
  • NA, not available